BRUSSELS: The European Commission has launched legal proceedings against Anglo-Swedish drugmaker AstraZeneca for not respecting its contract for the supply of COVID-19 vaccines, and for not having a "reliable" plan to ensure timely deliveries.
A first hearing in the case will be held at the Brussels Court of First Instance from 9 a.m. (0700 GMT) on Wednesday.
The proceedings will be public and conducted under an emergency procedure, which means they could be concluded in a matter of weeks, the European Union's executive Commission said.
HOW DID IT COME TO THIS?
The EU's decision to sue AstraZeneca came after the company repeatedly cut supplies to the 27-nation bloc, contributing to major delays in Europe's vaccine rollout, which has lagged those in Britain and the United States.
Under the contract, which was drawn up under Belgian law, the company committed to making its "best reasonable efforts" to deliver 300 million vaccine doses from December 2020 to June 2021, including 180 million in the current second quarter.
However, the company said in a statement on March 12 that it would aim to deliver only one-third of that 300 million total, of which about 70 million would be in the second quarter.
A week later, Brussels sent a legal letter to AstraZeneca, in the first step of potential court proceedings.
WHAT DOES ASTRAZENECA SAY?
AstraZeneca says the EU's legal action is without merit, argues that it complied with the contract, and has pledged to defend itself robustly in court.
WHAT'S IN IT FOR THE EU?
EU officials say the aim of the lawsuit is to compel AstraZeneca to deliver more vaccines than the number it has said it would aim to deliver.
The EU wants as many as possible of the promised 300 million doses, but would settle for 130 million by the end of June, an EU source familiar with the discussions told Reuters.
Brussels will also want AstraZeneca to explain to the court how it spent more than 224 million euros ($270 million) granted by the EU last September to buy vaccine ingredients, and for which the bloc said the company did not provide sufficient documents confirming the purchases.
If successful in court, the EU would send a warning to other vaccine suppliers. Pharmaceutical Johnson & Johnson has warned the EU it may not deliver the 55 million doses of its COVID-19 vaccine that it contracted to supply in the second quarter.
WHAT ARE THE RISKS FOR THE EU?
Some member states were initially reluctant to sue AstraZeneca on the grounds that it would take too long and, rather than speed up deliveries, only exacerbate tensions with a company they are still counting on for their vaccine campaigns.
If the EU loses its case in the Brussels court, it would be a public relations blow on top of criticism over its handling of vaccine purchase agreements and rollout of shots.
HOW FAR IS THE EU STILL RELYING ON ASTRAZENECA?
The AstraZeneca shot developed by Oxford University was supposed to be the main one in the EU vaccination campaign for the first half of this year.
However, the EU has now distanced itself from the company due to the supply problems and concerns over the efficacy and safety of the vaccine.
The bloc has forgone another 100 million AstraZeneca shots that it had an option to buy under the contract signed last August, and is now relying mostly on the Pfizer-BioNTech vaccine to inoculate at least 70% of EU adults by the end of July.
Still, while the AstraZeneca shot has been linked to very rare cases of blood clots, the EU drug regulator has recommended its use to contain the spread of COVID-19.
Reuters
Wed Apr 28 2021
The EU's decision to sue AstraZeneca came after the company repeatedly cut supplies to the 27-nation bloc, contributing to major delays in Europe's vaccine rollout, which has lagged those in Britain and the United States. REUTERSpic
ISIS Malaysia's perspective of Budget 2025
An excellent rakyat-centric budget under the overarching principle of a caring and humane economy.
Budget 2025: Record increase in STR, SARA aid initiatives
The government will provide a significant boost to the Sumbangan Tunai Rahmah (STR) and Sumbangan Asas Rahmah (SARA) initiatives next year.
Budget 2025: EPF contributions to be made mandatory for foreign workers – PM Anwar
The government plans to make it compulsory for all non-citizen workers to contribute to the Employees Provident Fund (EPF).
What policies to expect from Indonesia's new President Prabowo
Prabowo will be open to foreign investment, his aide has said, such as by offering investors management of airports and sea ports.
Budget 2025: Govt allocates RM470 mil to empower women's participation in PMKS
The Women's Leadership Apprenticeship Program will be intensified as an effort to produce more female corporate personalities.
Israel sends more troops into north Gaza, deepens raid
Residents of Jabalia in northern Gaza said Israeli tanks had reached the heart of the camp, using heavy air and ground fire.
Indonesia ramps up security ahead of Prabowo's inauguration
Prabowo Subianto will be sworn in as Indonesia's president on Sunday with Vice President-elect, Gibran Rakabuming Raka, also taking office.
Immediate allocation of RM150 mil for local authorities, DID to tackle flash floods
Datuk Seri Anwar Ibrahim said this allocation is intended to address the recent flash floods that hit the capital and several major towns.
Budget 2025: Sabah, Sarawak to continue receiving among highest allocations - PM
Sabah and Sarawak continues to be prioritised under Budget 2025, with allocations of RM6.7 billion and RM5.9 billion respectively.
NFOF will be operational in November 2024 with funding of RM1 bil
PM Anwar Ibrahim said NFOF will support venture capital fund managers to invest in startup companies with RM300 million set aside for 2025.
Minimum wage to increase to RM1,700 effective Feb 1, 2025
The Progressive Wage Policy would be fully enforced next year with an allocation of RM200 million, benefiting 50,000 workers.
Bursa Malaysia ends higher on Budget 2025 optimism
The benchmark index, which opened 1.85 points higher at 1,643.29, moved between 1,641.71 and 1,649.31 throughout the trading session.
Five important aspects relating to people’s lives in Budget 2025 - PM
The focus is on driving the MADANI Economy, speeding reforms, cutting red tape, raising wages, and tackling the cost of living.
Economic outlook: Govt plans to leverage, expand existing city transit system
The expansion aims to provide a more efficient and reliable public transportation network, reduce congestion, and improve accessibility.
Economic outlook: Budget 2025 to lay foundation for a digital-driven economy
The report said Budget 2025 will entail efforts to position Kuala Lumpur as a top 20 global startup hub by 2030 through the KL20 initiative.
Economic outlook: Corruption and lack of accountability hinder economic progress
Special Cabinet Committee on National governance is established to curb corruption, law reforms to modernise outdate regulations, MoF said.
National Wages Consultative Council will be strengthened
The govt will also incentivise hiring women returning from career breaks, offer job matching and improve care services facilities.
Economic outlook: Ensuring 11 years of compulsory education for all children
Budget 2025 will continue prioritising upskilling and retraining initiatives to equip workers with the latest skill sets necessary.
Consolidated public sector projected to record lower surplus of RM41.7 bil 2024
The MoF said the consolidated general government revenue is estimated to increase slightly to RM384.7 billion in 2024.
PM announces substantial Budget 2025 hastening Malaysia to become Asian economic powerhouse
Datuk Seri Anwar Ibrahim said it would create jobs and also tackle financial leakages to enhance public spending efficiency.